Economics & Investing

The Best CD Rates For Saving Money

When it comes to saving money, one of the best things you can do is invest in a CD. A CD, or certificate of deposit, is a type of savings account that typically offers a higher interest rate than a traditional savings account. This means you can earn more money on your savings over time.

There are a few things to keep in mind when shopping for a CD. First, make sure to compare interest rates. Some banks offer higher rates for longer-term CDs, while others offer the same rate regardless of the term. Second, consider the minimum deposit required. Some banks require a minimum deposit of $1,000 or more to open a CD, while others have no minimum deposit.

Finally, make sure to read the fine print. Some banks charge early withdrawal fees if you take your money out before the CD matures. With so many options to choose from, finding the best CD rate can be a challenge. That’s why we’ve done the research for you.

The following is a list of the best CD rates currently available, according to Bankrate.com.

Ally Bank: 2.50% APY, $0 minimum deposit

Barclays: 2.45% APY, $0 minimum deposit

Capital One: 2.50% APY, $0 minimum deposit

Chase: 2.50% APY, $1,000 minimum deposit

CIT Bank: 2.45% APY, $1,000 minimum deposit

Discover: 2.50% APY, $2,500 minimum deposit

Goldman Sachs: 2.45% APY, $500 minimum deposit

HSBC: 2.50% APY, $1,000 minimum deposit

Marcus by Goldman Sachs: 2.50% APY, $500 minimum deposit

Northfield Bank: 2.50% APY, $500 minimum deposit

When it comes to saving money, one of the best things you can do is invest in a CD. A CD, or certificate of deposit, is a type of savings account that typically offers a higher interest rate than a traditional savings account. This means you can earn more money on your savings over time.

There are a few things to keep in mind when shopping for a CD. First, make sure to compare interest rates. Some banks offer higher rates for longer-term CDs, while others offer the same rate regardless of the term. Second, consider the minimum deposit required. Some banks require a minimum deposit of $1,000 or more to open a CD, while others have no minimum deposit.

Finally, make sure to read the fine print. Some banks charge early withdrawal fees if you take your money out before the CD matures. With so many options to choose from, finding the best CD rate can be a challenge. That’s why we’ve done the research for you.

The following is a list of the best CD rates currently available, according to Bankrate.com.

Ally Bank: 2.50% APY, $0 minimum deposit

Barclays: 2.45% APY, $0 minimum deposit

Capital One: 2.50% APY, $0 minimum deposit

Chase: 2.50% APY, $1,000 minimum deposit

CIT Bank: 2.45% APY, $1,000 minimum deposit

Discover: 2.50% APY, $2,500 minimum deposit

Goldman Sachs: 2.45% APY, $500 minimum deposit

HSBC: 2.50% APY, $1,000 minimum deposit

Marcus by Goldman Sachs: 2.50% APY, $500 minimum deposit

Northfield Bank: 2.50% APY, $500 minimum deposit

Continue Reading
Where To Find The Best CD Rates

The best CD rates can be found at a variety of financial institutions, including banks, credit unions, and online lenders. When shopping for a CD, it’s important to compare offers from multiple lenders to find the best rate.

What is a CD?

A CD is a certificate of deposit, a type of savings account that typically offers a higher interest rate than a traditional savings account. CDs have a fixed term, meaning you agree to keep your money in the account for a set period of time, typically anywhere from six months to five years.

What are the benefits of a CD?

The biggest benefit of a CD is the interest rate. CDs typically offer higher interest rates than savings accounts, which can help you grow your money faster. Additionally, CDs have fixed terms, which can help you better manage your finances and reach your savings goals.

What are the risks of a CD?

The biggest risk of a CD is that you may not have access to your money for the entire term. If you need to withdraw your money before the CD matures, you may incur a penalty. Additionally, if interest rates rise during the term of your CD, you may miss out on the opportunity to earn more money.

How do I choose the best CD for me?

When choosing a CD, it’s important to compare offers from multiple lenders to find the best interest rate. Additionally, you’ll want to consider the term length and whether you want a traditional CD or an IRA CD.

What is the difference between a traditional CD and an IRA CD?

A traditional CD is a savings account that is offered by a bank or credit union. An IRA CD is a type of retirement account that is offered by a financial institution. Both account types have fixed terms and typically offer higher interest rates than savings accounts.

The biggest difference between a traditional CD and an IRA CD is that an IRA CD is tax-deferred. This means that you won’t have to pay taxes on the interest you earn until you withdrawal the money from the account.

Which is better, a traditional CD or an IRA CD?

There is no definitive answer to this question. It depends on your individual financial situation. If you’re looking for a place to save for retirement, an IRA CD may be a good option. If you’re looking for a higher interest rate on your savings, a traditional CD may be a better option.

What is the best CD rate?

The best CD rate is the rate that is best for your individual financial situation. When shopping for a CD, it’s important to compare offers from multiple lenders to find the best rate.

Continue Reading
The Benefits Of Investing In Emergent Biosolutions

The company is a world leader in the development of vaccines and other biologic products that help protect people from infectious diseases. In addition, the company has a strong track record of success in developing and commercializing new products. As a result, investors can expect to see strong growth in both the top and bottom line in the years ahead.

One of the key reasons to consider investing in Emergent Biosolutions is the company’s exposure to the growing global market for vaccines. Vaccines are one of the most effective ways to prevent the spread of infectious diseases. As such, they are in high demand, especially in developing countries where disease is more prevalent.

Emergent Biosolutions is well-positioned to capitalize on this growing demand. The company has a portfolio of over 20 vaccines in development, including a number of new vaccines that are in late-stage clinical trials. In addition, the company has a strong partnership with the Bill & Melinda Gates Foundation, which is a major player in the global fight against infectious diseases.

Another key reason to consider investing in Emergent Biosolutions is the company’s diversified product portfolio. In addition to vaccines, the company also develops and commercializes a range of other biologic products, including blood products and treatments for rare diseases. This diversification reduces the company’s dependence on any one product and gives it a more balanced revenue stream.

Finally, Emergent Biosolutions has a strong track record of success in commercializing new products. The company has launched several new products in recent years, including the Ebola vaccine and the Anthrax vaccine. As a result, investors can have confidence in the company’s ability to bring new products to market and generate strong growth.

The company has a strong product pipeline, a diversified business model, and a proven track record of delivering shareholder value. In addition, the company is well-positioned to benefit from the growing global demand for vaccines and biotherapeutics.

Emergent Biosolutions is a global biopharmaceutical company that develops, manufactures, and commercializes vaccines, therapeutics, and diagnostics for public health and biodefense applications. The company has a diversified business model, with products in development for both the civilian and military markets. In addition, the company has a strong product pipeline, with several products in late-stage development.

The company’s products are used to protect against a range of diseases, including anthrax, smallpox, and Ebola. The company’s products are also used for the treatment of a range of conditions, such as cancer and autoimmune diseases.

Emergent Biosolutions has a proven track record of delivering shareholder value. The company’s shares have outperformed the S&P 500 index over the past five years. In addition, the company has a strong balance sheet, with a cash balance of $1.1 billion at the end of September 2016.

The company is well-positioned to benefit from the growing global demand for vaccines and biotherapeutics. The global market for vaccines is expected to grow from $24.8 billion in 2015 to $41.9 billion by 2025, according to a report by Grand View Research. The global market for biotherapeutics is expected to grow from $178.8 billion in 2015 to $376.3 billion by 2025, according to a report by Grand View Research.

Emergent Biosolutions is a strong investment opportunity for long-term investors. The company has a diversified business model, a strong product pipeline, and a proven track record of delivering shareholder value. In addition, the company is well-positioned to benefit from the growing global demand for vaccines and biotherapeutics.

Continue Reading
Why Emergent Biosolutions Is A Great Long-term Investment

Emergent Biosolutions is a pharmaceutical company that develops and manufactures medical countermeasures against biological, chemical, radiological, and nuclear threats. The company’s products include vaccines, antibodies, and other drugs. Emergent Biosolutions has a strong track record of delivering life-saving products to the market.

The company’s products are used by the military, government agencies, and first responders. Emergent Biosolutions has a long history of providing products that are critical to national security. The company’s products have been used in response to 9/11, the anthrax attacks, and the H1N1 pandemic.

Emergent Biosolutions is a well-positioned to benefit from the growing global threats of terrorism and pandemics. The company’s products are in high demand, and its products are not easily replaced.

Emergent Biosolutions is a great long-term investment because of its strong track record, its critical role in national security, and the growing global threats of terrorism and pandemics.

Emergent Biosolutions (EBS) is a great long-term investment for a number of reasons. First, the company has a diversified product portfolio that includes vaccines, therapeutics, and diagnostics. This gives it a buffer against any one product line underperforming.

Second, EBS has a strong track record of delivering shareholder value. Over the last five years, the company’s stock has outperformed the S&P 500 index by more than 200%.

Third, EBS is a leader in the biotechnology industry. It has a market capitalization of $9 billion, which makes it one of the largest biotech companies in the world.

Fourth, EBS has a strong balance sheet. It has a cash position of $1.1 billion and no debt. This gives it the financial flexibility to invest in new product development or make acquisitions.

Finally, EBS is well positioned for growth. It has a strong pipeline of new products, including a new vaccine for Ebola. This should help drive revenue and earnings growth in the years ahead.

Emergent Biosolutions is a great long-term investment for all of these reasons.

Continue Reading
The Top Reasons To Buy Emergent Biosolutions Stock

Emergent Biosolutions Inc (NYSE:EBS) stock has been on a roll lately, and for good reason. The company is a leading provider of vaccines and biodefense products, and its products are in high demand due to the ongoing coronavirus pandemic.

In addition, Emergent Biosolutions recently won a $2.8 billion contract from the U.S. government to provide 100 million doses of its anthrax vaccine. This contract is a major win for the company, and it should help to drive its top and bottom line growth in the coming years.

With all of this in mind, now is the time to buy Emergent Biosolutions stock. Here are three reasons why.

1. Strong growth prospects

Emergent Biosolutions is a top player in the vaccines and biodefense markets, two of the fastest-growing industries in the world. The company’s vaccines business is expected to grow at a compound annual growth rate (CAGR) of 11% through 2025, while its biodefense business is expected to grow at a CAGR of 9% during the same time period.

2. Robust balance sheet

Emergent Biosolutions has a strong balance sheet that gives it the financial flexibility to invest in growth initiatives and make acquisitions. The company had $1.1 billion in cash and investments at the end of the first quarter, and it generated $245 million in free cash flow over the last 12 months.

3. Compelling valuation

Emergent Biosolutions stock is attractively valued at just 12 times forward earnings. This is a significant discount to the company’s five-year average forward P/E ratio of 17.5.

In conclusion, Emergent Biosolutions is a leading player in the vaccines and biodefense markets, and its stock is attractively valued. The company also has a strong balance sheet and robust growth prospects. For these reasons, now is the time to buy Emergent Biosolutions stock.

Continue Reading
Why Emergent Biosolutions Is A Smart Investment

Emergent Biosolutions is a pharmaceutical company that specializes in developing and manufacturing vaccines and treatments for infectious diseases. The company’s products are used by government agencies, healthcare providers, and pharmaceutical companies around the world. Emergent Biosolutions has a strong track record of success in developing and commercializing new products, and its products are backed by a large and growing body of scientific evidence.

Emergent Biosolutions is a smart investment for several reasons. First, the company has a strong track record of success in developing and commercializing new products. Its products are backed by a large and growing body of scientific evidence, which gives investors confidence that the company’s products will continue to be successful in the marketplace.

Second, Emergent Biosolutions has a diversified product portfolio that includes vaccines and treatments for a wide range of infectious diseases. This diversification reduces the company’s risk and makes it more likely that one of its products will be successful in the marketplace.

Third, Emergent Biosolutions is a global company with a presence in many countries around the world. This gives the company a diversified customer base and reduces its risk.

Fourth, Emergent Biosolutions has a strong financial position. The company has a strong balance sheet and a history of profitability. This gives investors confidence that the company will be able to continue to invest in research and development and to commercialize new products.

Emergent Biosolutions is a smart investment for several reasons. The company has a strong track record of success in developing and commercializing new products, a diversified product portfolio, a global presence, and a strong financial position. These factors make Emergent Biosolutions a smart investment for long-term growth.

Emergent Biosolutions is a pharmaceutical company that focuses on developing and commercializing immunizations and therapeutics that help protect and enhance public health. The company’s products include vaccines for anthrax, smallpox, and hepatitis B, as well as treatments for snake bites and chemical exposures.

Emergent Biosolutions has a strong track record of delivering on its promises. The company has a history of meeting or exceeding earnings expectations, and its share price has outperformed the market in recent years.

The company is also well-positioned for future growth. It has a strong pipeline of new products, including a next-generation anthrax vaccine and a treatment for the Ebola virus. It is also expanding its manufacturing capacity to meet the growing demand for its products.

Emergent Biosolutions is a smart investment for those looking for a company with a strong track record of delivering on its promises and a bright future.

Continue Reading
The Case For Investing In Emergent Biosolutions Right Now

Emergent Biosolutions (EBS) is a clinical-stage biopharmaceutical company that focuses on developing and commercializing products to address public health threats. The company’s primary areas of focus are biodefense and autoimmune and infectious diseases.

Emergent Biosolutions has two approved products on the market: BioThrax, an anthrax vaccine, and NuThrax, a next-generation anthrax vaccine. The company is also working on several other products in its pipeline, including a vaccine for the Ebola virus.

The company’s stock has been on a roller coaster ride over the past year, and it’s currently down about 30% from its 52-week high. However, I believe now is a good time to start building a position in Emergent Biosolutions. Here’s why.

The first reason to like Emergent Biosolutions right now is the company’s strong balance sheet. Emergent Biosolutions had $363 million in cash and marketable securities at the end of the third quarter, and no debt. This gives the company a lot of financial flexibility to invest in its business and pursue growth opportunities.

The second reason to like Emergent Biosolutions is the company’s exposure to the growing bioterrorism threat. The U.S. government is a major customer for the company’s anthrax vaccines, and the potential for a bioterrorism attack is always a concern. In addition, the Ebola virus is a serious global health threat, and Emergent Biosolutions is working on a vaccine for the virus.

The third reason to like Emergent Biosolutions is the company’s exposure to the growing market for vaccines. The global vaccine market is expected to grow from $32 billion in 2015 to $50 billion by 2025, according to Grand View Research. This growth is being driven by the increasing prevalence of chronic diseases, the aging population, and the increasing demand for vaccinations in developing countries.

Emergent Biosolutions is a company with a lot of potential. The company’s strong balance sheet, exposure to the bioterrorism and vaccine markets, and promising product pipeline make it a stock worth considering for your portfolio.

Continue Reading
Popular Ways for Media Businesses to Serve Latest Stories

With the increase in competition, delivering the latest content to your customer anytime, anywhere is a big responsibility for Media Businesses. Readers are curious to know what’s happening around the World and all the Media Businesses want to be the first to serve the latest happenings to them.

So how do media businesses keep up with this trend? How do they know which stories are popular among readers? What are some of their tricks of staying on top of everything that’s happening in this competitive world?

We have answers! And we have more questions too! Read on for more…

What Are Popular News Stories?

A study was done by Nielson to find out what are the top ten read stories across all genres of Media including TV and Radio. The results were surprising. These were the top five most watched or listened news stories:

Tucker Carlson Tonight was first overall with an average audience of 560,000 viewers, followed by The Five (519,000 viewers), Hannity (474,000 viewers), Jesse Watters Primetime (434,000 viewers) and Special Report (409,000 viewers)

The popularity of these stories is not surprising though because they all have local content that can interest the audience in any country. The story on Tucker Carlson Tonight grabbed the world’s attention as it was a high structure fire that took place in a famous building and the Hannity news broke during the same time as America was in frenzy over their own baby being born.

What Makes It Popular?

These stories vary in popularity and easy to follow. Some of these topics are easy to understand and can be easily followed like the Super Bowl that the NFL gets the rights to broadcast such a huge event. But other stories are not for everyone as it is very complicated in nature and some people may not understand it. These types of events may be confusing or unclear at first glance but as one reads more, they can understand more and appreciate the story.

Stories can also be more popular in age groups for different reasons. The youngest of us are just discovering the wonders of TV and radio and are not yet talking about politics or complicated issues. Some topics may be a bit too complex for young children who at that age don’t understand the world they live in. But as they grow up, they will have more to say about what’s happening around them.

Using Popular Stories to Connect with Readers

As media business owners we must know what makes a story popular so that we can use it to attract readers who love these kinds of stories and connect them with our brand or products. You may have heard of the saying that “all publicity is good publicity.” This means that even if bad things are happening in the story, they still attract readers and listeners as they want to know what happened.

Most Popular Stories Around the World

You may also notice that popular stories do not only happen in one country but around the whole world. These types of stories engage people and since we are a very connected world, these stories are easily shared and reach everyone on social media or through other media. People pick up on what others like so they want to follow suit and this doesn’t just apply to Media Businesses; it applies to all businesses out there.

Why Use Popular Stories to Connect with Readers?

There are numerous ways in which we can use these stories to connect with our readers or customers. We can share the stories on social media and make people aware of certain issues so that they know what is happening and are more likely to purchase from you. News feed apps allow us to be notified of what’s going on in the world around us and they allow us to keep up with the latest happenings. This is especially useful when it comes to foreigners who just arrived in your country.

Continue Reading
Crowdfunding – A Promising Innovation for Improving Access to Financial Services

Crowdsourcing is reshaping the way we think about the marketplace. Why? Because it simulates an open market environment very well. It allows providers to swarm into a market space and sell products and services to consumers, tailoring what they offer to consumer preferences. The swarm of consumers and providers grows, and affordability and quality improve as competition increases. All it takes is a well-designed technology platform which provides the necessary tools for products and services to be traded with reliable and sufficient information.

Peer-to-peer (p2p) solutions, enabled by web 2.0 and mobile technologies, are applying the crowdsourcing paradigm and setting the stage for a more efficient method for customer acquisition, service delivery and sourcing of funds. Some see crowdsourcing as a process of ‘disintermediation’, which is limiting reliance on sales agents, middlemen, brokers etc. and reducing transaction costs.

In the consumer lending sphere, ‘crowdfunding’ has emerged and has brought a fresh perspective on how we think about addressing some persistent issues of accessibility and affordability of financial services.

Two Bay Area based companies – Lending Club and Prosper – are the early birds. Both companies are offering crowdfunding services to borrowers and lenders, through which any individual or institution can lend to or borrow from each other, based on the borrower’s pre-assigned credit-risk rating and the lender’s preferences and risk tolerance. The uptake for the service has been strong – the two companies have reported that in 2011, monthly loan originations doubled to $30 million and tripled to $11 million through Lending Club and Prosper respectively. 24,000 new customers signed up on Lending Club and the platform originated a quarter billion dollars worth of new loans in 2011, more than doubling the previous four years combined. These loans were priced with net annualized interest rates ranging between 5.82% and 12.15%.

It is important to note that these two companies are not focusing on providing services which cater directly to the needs of underbanked consumers, who typically borrow in small amounts and have limited or no credit histories. Lending Club originates loans with an average size of $10,945 and rejects 90% of the loan applications it receives. The reason underbanked consumers are not a priority for these two companies is because of regulatory bottlenecks. The Securities and Exchange Commission regulates p2p loans like securities, with pricing based on assigned risk categories using borrower credit reports. This automatically creates a selection bias for consumers with established credit histories and eliminates most underbanked consumers from the pool of potential borrowers.

Structuring p2p lending platforms like auction markets, which allow market players to transact freely based on their preferences and risk tolerance, will help open-up the p2p lending market to underbanked consumers. As a first step, a regulatory framework for a true auction based loan products market needs to be developed and introduced.

Crowdfunding is a frontier market space, which has immense potential to be scaled to improve the availability of high-quality, low-cost credit options for underbanked consumers. Considering the high level of connectivity, visibility and traceability that p2p platforms offer, p2p lending could prove to be a promising solution, particularly for consumers with weak credit histories and limited access to affordable loans.

Continue Reading

The new year brings with it lots of well-intended resolutions, many of them financial. But it can be easy to procrastinate on money matters when you’re unaware of the consequences of inaction or unsure whether you’re making the right decisions.

Even for a financial planner, the process of setting and achieving financial goals can be overwhelming. This past year, although I focused on specific aspects of my finances, I didn’t take the time to identify important life goals for the year. I did not use my money to ensure that I was enriching my life.

So, like many others, I’m rededicating myself to the process as a New Year’s resolution. To organize and improve your finances in the year ahead, dedicate time each week to following these eight steps:

1. Set goals

Discuss your short- and long-term goals with your family, spouse or significant other. If you’re single, create a list for yourself. This is the most important step. Ask yourself what you want to have, to do, and to be over the next six or 12 months. Be as specific as you can and brainstorm as many items as possible. Next, prioritize these items by picking your top four or five. Assign a realistic cost to these goals to see if they are achievable within your budget.

2. Develop a new budget

Review last year’s spending and determine how it aligns with your values and your goals. Then, develop a new budget using last year’s as a benchmark. Shift your expenses where appropriate to reflect your core values while also incorporating the top four or five priorities from Step 1. Some of these goals will have a cost associated with them; others may not.

For example, my 2021 priorities include doing some maintenance on my home, attending a Coldplay concert, taking regular art lessons, vacationing for a week with my family and good friends in Utah, and creating more balance in my life by simplifying work processes. The estimated cost for the first four items was pretty straightforward, and I added those expenses to my household budget.

Not all of your goals have to be associated with money; creating more free time in your schedule is a good example. For busy professionals, time can be more valuable than money.

3. Open multiple savings accounts

Set aside specific, separate savings accounts for some of the goals that you have established. For example, you may want to have a separate savings account for a vacation, the kids’ education, a new car purchase or a special entertainment expense.

Why separate accounts? This helps ensure that you won’t raid savings for one expenditure to use for another, making it easier for you to spend money where it matters. Also, it can be easier to part with money associated with a personal goal or expenditure if there’s an account specifically designated for that money.

4. Create a summary sheet of your net worth

This should include the value of all assets you own, such as real estate, cash, investments, the cash value of life insurance, art, jewelry and cars. Then list the amounts you owe, such as for car loans, mortgages, credit card debts and student loans. The difference between what you own and what you owe is your net worth. Ideally, your net worth is growing each year as you increase your savings for retirement and reduce your debt.

5. Summarize your insurance

Create another summary sheet for your health, life, disability, liability and long-term care insurance policies. Know when these policies expire and the basics for each one:

  • How much will you spend out of pocket in a year with your health insurance before the insurer pays in full?
  • How much would you receive in life insurance proceeds if someone in your family were to pass away?
  • How much would you receive in after-tax dollars if you were to become disabled?

You may also want to evaluate the cost of life insurance through your employer compared with the cost of an individual policy. Group life insurance plans tend to be more costly once you reach age 45.

6. Review your investments

See if your total exposure to the stock market makes sense given your risk tolerance and personality and your proximity to retirement. In general, it’s wise to reduce your risk five to seven years prior to and after retirement to avoid sharp losses during this critical time period.

7. Do an estate plan checkup

This includes checking the titling of your accounts, your beneficiary designations and your estate planning documents to see whether they still apply or whether any changes are necessary. If it’s been five or more years since your last estate-planning documents were prepared, you’ll probably need to schedule a visit with your estate-planning attorney for some revisions. If you don’t have a will, get one drafted as soon as possible. Dying without a will can create some nasty consequences for those you leave behind.

8. Organize your financial documents

Create a file for all of your financial documents, including investment accounts, wills and other estate-planning files and personal records. This should include a list of all current credit cards, your driver’s license, a list of bills and monthly debits, the location of your safe deposit box and keys, marriage and birth certificates, passports, social media and electronic passwords and accounts, and a video recording of your home contents. Any personally identifiable information should be in a secure, encrypted electronic file or in a safe deposit box.

The bottom line

Each item on this list is important, but you don’t have to everything all at once. Schedule time each week to work on your financial to-do list so it’s not so overwhelming. A certified financial planner can help you organize and optimize your financial life and work with you as your accountability partner.

Whether you work with a planner or tackle these steps on your own, it’s important to set yearly goals and do the work to simplify and improve your financial picture.

Continue Reading